Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation and Physical Activity in Parkinson's Disease
NCT04768023Completed
- Sponsor
- Medical University of Gdańsk
- Start
- Nov 2019
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of vitamin d in Parkinson's disease (PD) (2 arms), sponsored by Medical University of Gdańsk. Primary endpoints: Concentration of vitamin D3 in serum at 12 weeks, Concentration of inflammatory markers in serum at 12 weeks and 5 more. Started Nov 2019; status: completed.
02
Drugs
vitamin d
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04768023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04768023.